Your Article Summary
Defining cancer risk in dermatomyositis
Clinical and Experimental Dermatology, 06/09/09
Madan V et al. - The idiopathic inflammatory myopathies (IIMs) comprise polymyositis, myositis overlapping with another connective tissue disease, dermatomyositis (DM) and inclusion-body myositis (IBM). IIMs are characterized by the presence of proximal muscle weakness, increased levels of muscle-specific enzymes, specific electromyographic abnormalities, and the presence of inflammatory cell infiltrates in skeletal muscle.
Related Articles
Dermatomyositis and HIV infection: case report and review of the literature
Rheumatology International, 11/16/09
Relevance Score: 90%
A histopathologic study of mechanics hands associated with dermatomyositis: a report of five cases
International Journal of Dermatology, 10/28/09
Relevance Score: 85%
Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
Best Practice & Research: Clinical Rheumatology, 10/28/09
Relevance Score: 85%
Dermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09
Relevance Score: 85%
Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis
Scandinavian Journal of Rheumatology, 10/08/09
Relevance Score: 85%
Today in Autoimmune/Bullous Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid
Medical Hypotheses, 12/09/09
Genetic basis of oculocutaneous albinism
Expert Review of Dermatology, 12/08/09
Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways
British Journal of Dermatology, 12/10/09
New insights into pigmentary pathways and skin cancer
British Journal of Dermatology, 12/10/09
Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients
Annals of Surgical Oncology, 12/10/09

See Latest Articles